首页> 外文期刊>Leprosy review >ACCOMPANIED MDT (AMDT)―MORE QUESTIONS THAN ANSWERS
【24h】

ACCOMPANIED MDT (AMDT)―MORE QUESTIONS THAN ANSWERS

机译:伴随MDT(AMDT)-比答案更多的问题

获取原文
获取原文并翻译 | 示例
           

摘要

Accompanied MDT (AMDT), an essential element of the 'flexible and patient-friendly MDT delivery systems' recommended by WHO, is a policy in which the patient is provided the entire supply of MDT drags at the time of diagnosis―6 months of medication for a paucibacillary (PB) patient and 12 months for a multibacillary (MB) patient, while asking 'someone close to or important to the patient assumes the responsibility of helping him or her complete a full course of treatment'. Recently, the Global Alliance for Leprosy Elimination (GAEL) and the WHO Technical Advisory Group on Elimination of Leprosy (TAG) have recommended that 'AMDT should be widely implemented in order to increase accessibility of all patients (to MDT).' because of the prestige of these institutions, the AMDT policy has been widely implemented in the field. AMDT is one of the more controversial technical policies that have been introduced into leprosy control, because it deviates fundamentally from the principle of supervised administration of the monthly component of standard MDT regimens, and may therefore damage seriously the quality of treatment by MDT. The purpose of this paper is to call attention to the flaws of AMDT. Because poor adherence is also a common phenomenon among tuberculosis (TB) patients, as the result of which directly observed treatment (DOT) has been widely applied as the 'standard of cure' for treatment of TB, the relevant experience from TB programmes is reviewed.
机译:世卫组织建议,伴随性的MDT(AMDT)是世卫组织推荐的“灵活且对患者友好的MDT输送系统”的基本要素,该政策是在诊断时(服药6个月)向患者提供全部MDT药物对于一个脓疱(PB)患者,对于一个多细菌(MB)患者,为12个月,同时询问“与患者密切或重要的人承担帮助他或她完成整个治疗过程的责任”。最近,全球消除麻风病联盟(GAEL)和世界卫生组织消除麻风病技术咨询小组(TAG)建议“应广泛实施AMDT,以增加所有患者(MDT)的可及性”。由于这些机构的声望,AMDT政策已在该领域得到广泛实施。 AMDT是已引入麻风病控制的更具争议的技术政策之一,因为它从根本上偏离了标准MDT方案每月组成部分的监督管理原则,因此可能严重损害MDT的治疗质量。本文的目的是引起人们对AMDT缺陷的关注。由于依从性差也是结核病(TB)患者中的普遍现象,因此直接观察治疗(DOT)已被广泛用作治疗结核病的“治愈标准”,因此对结核病项目的相关经验进行了回顾。

著录项

  • 来源
    《Leprosy review》 |2002年第4期|p.301-307|共7页
  • 作者

    BAOHONG JI;

  • 作者单位

    Bacteriologie et Hygiene Faculte de Medecine Pitie-Salpetriere 91, boulevard de l'Hopital 75634 Paris, France;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 皮肤病学与性病学;传染病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号